Regeneron Pharmaceuticals REGN
NASDAQ REGN
$902.90 -27.77 (-2.98%)
At close: Nov 5, 2026 · 4:00 PM EST

Regeneron Pharmaceuticals (REGN) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Analysis

Regeneron Pharmaceuticals (REGN) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn 197.43 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn 147.68 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn - -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn 119.92 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn 205.00 Bn
10 Regeneron Pharmaceuticals 91.70 Bn 57.05 Bn 4.54 Bn 44.41 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 44.41 Bn
Jun 30, 2026 41.73 Bn
Mar 31, 2026 40.87 Bn
Dec 31, 2025 40.56 Bn
Sep 30, 2025 40.17 Bn
Jun 30, 2025 38.22 Bn
Mar 31, 2025 37.55 Bn
Dec 31, 2024 37.76 Bn
Sep 30, 2024 37.44 Bn
Jun 30, 2024 36.09 Bn
Mar 31, 2024 34.37 Bn
Dec 31, 2023 33.08 Bn
Sep 30, 2023 32.16 Bn
Jun 30, 2023 30.66 Bn
Mar 31, 2023 30.06 Bn
Dec 31, 2022 29.21 Bn
Sep 30, 2022 27.68 Bn
Jun 30, 2022 27.21 Bn
Mar 31, 2022 26.35 Bn
Dec 31, 2021 25.43 Bn
API Access

Regeneron Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=REGN&period=max&api_key=YOUR_API_KEY